Last reviewed · How we verify
Thromboembolic pulmonary hypertension
Approved treatments
- Remodulin · United Therap
Remodulin works by activating the prostacyclin receptor, which causes blood vessels to relax and widen. - Uptravi · AstraZeneca
Uptravi works by activating the prostacyclin receptor, which helps to relax blood vessels and improve blood flow.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Thromboembolic pulmonary hypertension patent landscape — cliff calendar, originator estates, attackable patents
- Thromboembolic pulmonary hypertension treatment landscape brief
- Thromboembolic pulmonary hypertension treatment updates RSS
Frequently asked questions about Thromboembolic pulmonary hypertension
What drugs treat Thromboembolic pulmonary hypertension?
Tracked treatments include Remodulin, Uptravi.
What is the treatment for Thromboembolic pulmonary hypertension?
Standard treatment for Thromboembolic pulmonary hypertension includes Remodulin, Uptravi. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Thromboembolic pulmonary hypertension patent cliff · Thromboembolic pulmonary hypertension CI report
- Treatment: Remodulin · United Therap
- Treatment: Uptravi · AstraZeneca
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing